James T Yoon

1PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Apr 03, 2025
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia.

James T Yoon, Yinglu Zhou, Mariia Mikhaleva

Pageof 1

Frequent Collaborators

1 joint publications

Yinglu Zhou

1 joint publications

Mariia Mikhaleva

1 joint publications

Jennifer L Crombie

1 joint publications

David C Fisher

1 joint publications

Austin I Kim

1 joint publications

Ann S LaCasce

1 joint publications

Oreofe O Odejide

1 joint publications

Erin M Parry

1 joint publications

David A Qualls

1 joint publications

Jennifer R Brown

Frequent Collaborators

1 joint publications

Yinglu Zhou

1 joint publications

Mariia Mikhaleva

1 joint publications

Jennifer L Crombie

1 joint publications

David C Fisher

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

392
See more related videos

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

392
See more related videos